Robert Goldberg is Chairman of Manhattan Institute’s 21st Century FDA Task Force.

He has written on the value of medical innovation, Medicare reform, reimportation of medicines from Canada and the role free market institutions have in promoting access to better medicines and health care. His current work examines the impact medical progress will have on people in the future and why medical innovation has so many enemies in Congress, activist groups and the media.

Goldberg is the author of numerous articles and reports including “Stealing U.S. drug patents,” “The Right Road to Safe Drugs,” “Don’t blame Canada,” and “Vioxx Backlash Could Derail Future of Medicine.” In February 2005, Goldberg testified before the Senate Committee on Heath, Education, Labor and Pensions on drug importation. He has written for The Wall Street Journal, The Washington Post, the Los Angeles Times, National Review Online, The Weekly Standard, The Chicago Tribune, The Philadelphia Inquirer, The New York Post, The New York Sun and writes regularly for The Washington Times. In June 2005, Goldberg was featured in a Question and Answer in Investor’s Business Daily on clinical trials.

He received his Ph.D. in Politics at Brandeis University in 1984. Robert Goldberg lives in New Jersey and has two children, Sara (20) and Zach (17), and his dog Samson.